In today's episode I'm going to cover the GLP1 medications on the horizon. These include CagriSema, retatrutide, survodutide, and amycretin. Then I'll compare and contrast the currently approved GLP1s. I'll go over which weight loss medications are approved at which ages for pediatrics. Lastly, I'll go over the hurdles of insurance coverage and give you an example of how the requirements for payment change and what those requirements are.

Podden och tillhörande omslagsbild på den här sidan tillhör Cody Armstrong, MD. Innehållet i podden är skapat av Cody Armstrong, MD och inte av, eller tillsammans med, Poddtoppen.